GIO

Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation

Retrieved on: 
Thursday, February 1, 2024

Edinburgh, Scotland, 1 February 2024 – Cumulus Oncology (a biotech creation company) today proudly unveils the inauguration of GIO Therapeutics AG, based in Basel, Switzerland.

Key Points: 
  • Edinburgh, Scotland, 1 February 2024 – Cumulus Oncology (a biotech creation company) today proudly unveils the inauguration of GIO Therapeutics AG, based in Basel, Switzerland.
  • This newly established biotech company specialises in the development of pharmaceuticals targeting G protein-coupled receptors (GPCR).
  • Heading GIO Therapeutics is Dr Xavier Leroy who has been appointed as Chief Executive Officer.
  • Dr Xavier Leroy, CEO of GIO Therapeutics commented: “While GPCRs are well-known drug targets, their potential in cancer therapeutics is currently underutilised.

Apeiron Capital Investment Corp. Announces Termination of Business Combination Agreement and Liquidation

Retrieved on: 
Friday, August 11, 2023

BOSTON, MA , Aug. 11, 2023 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate the Business Combination Agreement between the parties, dated as of March 8, 2023 (as amended May 10, 2023, the “Business Combination Agreement”), pursuant to Section 8.1(b) thereof, effective as of August 14, 2023 (the “Termination”).

Key Points: 
  • BOSTON, MA , Aug. 11, 2023 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate the Business Combination Agreement between the parties, dated as of March 8, 2023 (as amended May 10, 2023, the “Business Combination Agreement”), pursuant to Section 8.1(b) thereof, effective as of August 14, 2023 (the “Termination”).
  • Upon the effectiveness of the Termination, the Business Combination Agreement will be of no further force and effect, with the exception of the specified provisions in Section 8.2 of the Business Combination Agreement, which shall survive the termination of the Business Combination Agreement and remain in full force and effect in accordance with their respective terms.
  • The redemption of the Public Shares is expected to be completed within ten business days after August 14, 2023.
  • There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

J.P. Morgan Private Bank announces new U.S. Family Office Practice

Retrieved on: 
Wednesday, July 26, 2023

NEW YORK, July 26, 2023 /PRNewswire/ -- J.P. Morgan Private Bank today announced the launch of its U.S. Family Office Practice , a new effort that will support the Private Bank's largest clients and their family enterprises, and expand its suite of family office services.

Key Points: 
  • NEW YORK, July 26, 2023 /PRNewswire/ -- J.P. Morgan Private Bank today announced the launch of its U.S. Family Office Practice , a new effort that will support the Private Bank's largest clients and their family enterprises, and expand its suite of family office services.
  • The U.S. Family Office Practice will be bolstered by a strong leadership and advisory team from across the Private Bank.
  • Elisa Shevlin Rizzo has joined the firm as the Head of Family Office Advisory for J.P. Morgan Private Bank and the new practice.
  • McCree's decade of experience at J.P. Morgan will serve the new practice as he works to uncover opportunities to grow the ultra-high-net-worth Private Bank business across the U.S.
    To learn more about J.P. Morgan Private Bank's new U.S. Family Office Practice, visit here .

Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors

Retrieved on: 
Thursday, July 6, 2023

David Bassin brings a wealth of expertise and experience in the healthcare industry, particularly in the field of wound care.

Key Points: 
  • David Bassin brings a wealth of expertise and experience in the healthcare industry, particularly in the field of wound care.
  • Prior to his role as CEO, Bassin served as the CFO of Healogics, contributing to the company's financial growth and success.
  • "We are thrilled to welcome David Bassin to the MolecuLight Board of Directors," said Anil Amlani, CEO of MolecuLight.
  • David Bassin expressed his excitement about joining MolecuLight's Board of Directors, stating, "There are over 6.5 million patients living with wounds.

Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors

Retrieved on: 
Thursday, July 6, 2023

TORONTO, July 6, 2023 /PRNewswire/ -- MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated, pathogenic bacterial loads in and around wounds, is pleased to announce the appointment of David Bassin to its Board of Directors as an Independent Board Member.

Key Points: 
  • David Bassin brings a wealth of expertise and experience in the healthcare industry, particularly in the field of wound care.
  • Prior to his role as CEO, Bassin served as the CFO of Healogics, contributing to the company's financial growth and success.
  • "We are thrilled to welcome David Bassin to the MolecuLight Board of Directors," said Anil Amlani, CEO of MolecuLight.
  • David Bassin expressed his excitement about joining MolecuLight's Board of Directors, stating, "There are over 6.5 million patients living with wounds.

Mission Critical Partners to Continue Its Support of Maryland's Statewide Transition to Next Generation 911 Service

Retrieved on: 
Tuesday, March 14, 2023

STATE COLLEGE, Pa., March 14, 2023 /PRNewswire-PRWeb/ -- Mission Critical Partners (MCP) announced today that it was awarded a three-year contract to support the state of Maryland's effort to aggregate, validate, and disseminate geographic information system (GIS) data in the state's multi-ESInet environment. MCP will ensure that the GIS data aligns with industry standards and best practices and is seamless across Maryland's Next Generation 911 (NG911) environment.

Key Points: 
  • MCP will ensure that the GIS data aligns with industry standards and best practices and is seamless across Maryland's Next Generation 911 (NG911) environment.
  • Broadband-enabled NG911 systems enable the transport of extremely large data files, e.g., video, and tremendous volumes of data, both of which would choke legacy narrowband 911 systems.
  • The goal is continual progress, because it takes about 18 months to prepare public-safety GIS data for use in the NG911 environment.
  • Over the years, MCP has helped clients identify and correct the thousands of errors that exist in every GIS database.

GIO World Health Ltd, a Leading Stem Cell Life Science Company, Announces Plans to Go Public via Business Combination with Apeiron Capital Investment Corp.

Retrieved on: 
Wednesday, March 8, 2023

BOSTON, MA and SAN DIEGO, CA , March 08, 2023 (GLOBE NEWSWIRE) -- GIO World Health, a recently formed company focused on stem cell research and development, and Apeiron Capital Investment Corp. (“Apeiron Capital”) (OTC: APNC), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement (the “BCA”) to bring GIO World Health public in order to bring its proprietary stem cell treatments to market, and other stem cell based products for global consumption.  The parties intend that at the closing of the proposed transaction (the “Closing”), Apeiron Capital common stock will be listed on either the New York Stock Exchange or NASDAQ, and Apeiron Capital will be renamed "GIO World Health Holdings, Inc.".

Key Points: 
  • The post-closing combined public company, which will be named GIO World Health Holdings, Inc., values GIO World Health in the proposed transaction at a pre-money enterprise value of $250 million.
  • GIO World Health, was founded in 2021 by Dr. Anand Srivastava and Deven Patel, accomplished professionals who have operated in the stem cell research and development field for over two decades.
  • GIO World Health is a stem cell-based life science company with plans to distribute selective products and services globally, and may also pursue FDA approval for more advanced therapies.
  • GIO World Health is planning to mass produce the Red Blood Cells (RBCs) from stem cells in a bioreactor to solve the blood shortage problem.

Taiwan’s best smart display manufacturers shine at 2022 SDIA Award

Retrieved on: 
Friday, November 11, 2022

To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.

Key Points: 
  • To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.
  • The aim is to commend the participating manufacturers for their investment in expanding forward-looking display technologies and to enhance the image and market competitiveness of Taiwan's display industry.
  • View the full release here: https://www.businesswire.com/news/home/20221110005513/en/
    Taiwans top smart display companies selected for 2022 SDIA Award (Photo: Business Wire)
    Founded by the Industrial Development Bureau of the Ministry of Economic Affairs in 2021, SDIA established industry-government-university-academia collaboration networks and an operation integration mechanism, strengthening cross-sector, inter-departmental, and multidisciplinary resources and capacity to increase Taiwans international competitiveness in smart display technology and encourage cross-industry collaborations to transform the display industry from a single industrial chain into an industrial ecosystem.
  • SDIA will continue to help manufacturers in the smart display industry to transform and upgrade with an aim to develop higher value-added products or system and application integration services.

Meet the winners of Taiwan’s Smart Display Industry Alliance Award

Retrieved on: 
Friday, November 11, 2022

To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.

Key Points: 
  • To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.
  • The aim is to commend the participating manufacturers for their investment in expanding forward-looking display technologies and to enhance the image and market competitiveness of Taiwan's display industry.
  • This year, the prizes are awarded to companies that delivered outstanding projects with a focus on forward-looking display technologies.
  • SDIA will continue to help manufacturers in the smart display industry to transform and upgrade with an aim to develop higher value-added products or system and application integration services.

Taiwan’s Top Smart Display Companies Selected for 2022 SDIA Award

Retrieved on: 
Friday, November 11, 2022

To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.

Key Points: 
  • To encourage Taiwans smart display manufacturers to stay up to date with the leading display technologies, the Smart Display Industry Alliance (SDIA) organized the 2022 SDIA Award, handing out Gold, Silver, and Bronze prizes as well as the Prize of Excellence to winners who meet the award evaluation criteria including marketability, innovation, technology, research and development capabilities, and prototype performance.
  • The aim is to commend the participating manufacturers for their investment in expanding forward-looking display technologies and to enhance the image and market competitiveness of Taiwan's display industry.
  • View the full release here: https://www.businesswire.com/news/home/20221110005508/en/
    Taiwans top smart display companies selected for 2022 SDIA Award (Photo: Business Wire)
    Founded by the Industrial Development Bureau of the Ministry of Economic Affairs in 2021, SDIA established industry-government-university-academia collaboration networks and an operation integration mechanism, strengthening cross-sector, inter-departmental, and multidisciplinary resources and capacity to increase Taiwans international competitiveness in smart display technology and encourage cross-industry collaborations to transform the display industry from a single industrial chain into an industrial ecosystem.
  • This year, the prizes are awarded to companies that delivered outstanding projects with a focus on forward-looking display technologies.